基本信息
浏览量:5
职业迁徙
个人简介
Dr Paul McKay is a senior researcher working within Professor Robin Shattock’s mucosal vaccinology team in the Department of Medicine. His primary research centres on the development of new vaccine candidates, the optimization of immunization regimens and the assessment of potential vaccine efficacy, with a particular focus on the generation of vaccine-induced immunity at the surface and within mucosal tissue.
Paul was awarded a B.Sc. (Hons) in Biochemistry from Imperial College, then a M.Sc. in Medical Immunology from The Royal Postgraduate Medical School (now the Hammersmith Campus of Imperial College, London) and finally a Ph.D. in Molecular Immunology, also from Imperial College. He then spent four years at Harvard Medical School and the Beth Israel Deaconess Medical Centre in Boston, USA, working for Professor Norman Letvin on the characterization of T cell responses to various vaccine modalities and the analysis, development and optimization of DNA prime and recombinant vector boost HIV vaccine candidates. He returned to the UK to work at St. George’s, University of London and was part of a successful application to the Bill and Melinda Gates Foundation and The Wellcome Trust for a Grand Challenges for Global Health Initiative program grant to optimize vaginal vaccination against HIV infection.
Paul is currently involved in a number of research programs awarded to Professor Robin Shattock and funded by CHAVI, the Center for HIV AIDS Vaccine Immunology funded by NIH, the EUROPRISE Network of Excellence on Vaccines and Microbicides, the Bill and Melinda Gates Grand Challenges for Global Health ‘Novel Antigen Design and Delivery for Mucosal Protection Against HIV-1 Infection’ initiative. He also holds a Sir Joseph Hotung Senior Fellowship and is based at St. George’s, University of London and Imperial College, London. He lectures on vaccine design and development and on T cell and Dendritic Cell biology and has successfully supervised a number of M.Sc., M.Res and Ph.D. students.
Paul was awarded a B.Sc. (Hons) in Biochemistry from Imperial College, then a M.Sc. in Medical Immunology from The Royal Postgraduate Medical School (now the Hammersmith Campus of Imperial College, London) and finally a Ph.D. in Molecular Immunology, also from Imperial College. He then spent four years at Harvard Medical School and the Beth Israel Deaconess Medical Centre in Boston, USA, working for Professor Norman Letvin on the characterization of T cell responses to various vaccine modalities and the analysis, development and optimization of DNA prime and recombinant vector boost HIV vaccine candidates. He returned to the UK to work at St. George’s, University of London and was part of a successful application to the Bill and Melinda Gates Foundation and The Wellcome Trust for a Grand Challenges for Global Health Initiative program grant to optimize vaginal vaccination against HIV infection.
Paul is currently involved in a number of research programs awarded to Professor Robin Shattock and funded by CHAVI, the Center for HIV AIDS Vaccine Immunology funded by NIH, the EUROPRISE Network of Excellence on Vaccines and Microbicides, the Bill and Melinda Gates Grand Challenges for Global Health ‘Novel Antigen Design and Delivery for Mucosal Protection Against HIV-1 Infection’ initiative. He also holds a Sir Joseph Hotung Senior Fellowship and is based at St. George’s, University of London and Imperial College, London. He lectures on vaccine design and development and on T cell and Dendritic Cell biology and has successfully supervised a number of M.Sc., M.Res and Ph.D. students.
研究兴趣
论文共 127 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nazgol Karimi Dastgerdi, Nurcan Gumus, Hulya Bayraktutan,Darryl Jackson,Krunal Polra,Paul F. Mckay,Fatemeh Atyabi,Rassoul Dinarvand,Robin J. Shattock, Luisa Martinez-Pomares,Pratik Gurnani,Cameron Alexander
Hulya Bayraktutan,Rafał Kopiasz, Amr ElSherbeny, Magda Martinez Espuga, Nurcan Gumus, Umut Can Oz,Krunal Polra,Paul F. McKay,Robin J. Shattock,Paloma Ordonez Moran,Alvaro Mata,Cameron Alexander,
Polymer Chemistry (2024)
Nazgol Karimi Dastgerdi, Nurcan Gumus, Hulya Bayraktutan,Darryl Jackson,Krunal Polra,Paul F. McKay,Fatemeh Atyabi,Rassoul Dinarvand,Robin J. Shattock, Luisa Martinez-Pomares,Pratik Gurnani,Cameron Alexander
Nanoscale Advancesno. 5 (2024): 1409-1422
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAno. 45 (2023)
John S. Tregoning, David C. Stirling,Ziyin Wang,Katie E. Flight,Jonathan C. Brown,Anna K. Blakney,Paul F. McKay, Robert F. Cunliffe,Valarmathy Murugaiah,Christopher B. Fox,Mitchell Beattie,Ying K. Tam,
Molecular therapy. Nucleic acids (2023): 29-42
Frontiers in immunology (2023): 1184510
引用0浏览0WOS引用
0
0
Frontiers in Microbiology (2023): 1247041-1247041
biorxiv(2022)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn